Annual Secretarial Compliance Report for the period March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Astal Laboratories Ltd filed its Annual Secretarial Compliance Report for FY 2025-26 under SEBI Regulation 24A. The report issued by Practicing Company Secretary Mahendra Khandelwal & Co. confirms the company has fully complied with all SEBI regulations including LODR, ICDR, SAST, PIT, and Depositories regulations. No deviations, fines, or observations were recorded. All 14 compliance checkpoints including secretarial standards, board evaluations, related party transactions, and insider trading norms were marked compliant. The report notes the company acquired SRIVEN PHARMACHEM INDIA PRIVATE LIMITED as a wholly-owned material subsidiary during the year. No penalties were imposed and no SEBI/Stock Exchange actions were taken against the company.
This is a positive compliance filing showing the company maintained full regulatory compliance throughout FY2025-26 with no violations or penalties, which is reassuring for investors regarding governance standards.